Page last updated: 2024-10-23

atenolol and Airflow Obstruction, Chronic

atenolol has been researched along with Airflow Obstruction, Chronic in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research Excerpts

ExcerptRelevanceReference
"Atenolol treated patients demonstrated more pronounced respiratory disorders."1.33[What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?]. ( Aĭsanov, ZR; Chuchalin, AG; Kozlova, LI, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cazzola, M1
Matera, MG1
Kozlova, LI1
Aĭsanov, ZR1
Chuchalin, AG1

Other Studies

2 other studies available for atenolol and Airflow Obstruction, Chronic

ArticleYear
Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
    American journal of respiratory and critical care medicine, 2008, Oct-01, Volume: 178, Issue:7

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Contraindi

2008
[What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?].
    Terapevticheskii arkhiv, 2005, Volume: 77, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Male; Middle Aged; Myocardial Ischemia;

2005